Alloimmunization in Transfusion Dependent Thalassaemic Patients.
Background: Life-long red blood cells (RBCs) transfusion remains the main treatment for severe cases of thalassaemia. The development of anti-RBC antibodies (alloantibodies and for autoantibodies) can significantly complicate transfusion therapy. Some alloantibodies are hemolytic and may cause, tho...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Medicine University of Baghdad
2010-04-01
|
| Series: | مجلة كلية الطب |
| Subjects: | |
| Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1058 |